Meloxicam Mylan

Meloxicam, the active ingredient in Meloxicam Mylan, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain. GNH USA supplies Meloxicam Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam Mylan belongs to the NSAID class and acts on inflammatory pathways that underlie several musculoskeletal disorders. - Osteoarthritis: reduces joint pain and swelling, improving mobility in patients with osteoarthritis. - Rheumatoid arthritis: alleviates chronic inflammation and joint damage associated with rheumatoid arthritis. - Ankylosing spondylitis: diminishes spinal inflammation and stiffness in ankylosing spondylitis. - Acute pain: provides rapid relief of moderate to severe acute musculoskeletal pain.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia. - Nausea or vomiting. - Diarrhea. - Headache. - Dizziness. - Mild skin rash.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Elevated liver enzymes or hepatic injury. - Severe cutaneous reactions (e.g., Stevens‑Johnson syndrome). - Acute renal impairment. - Anaphylactic or severe allergic reactions.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for complications. - Assess cardiovascular risk: review history of heart disease or stroke before prescribing. - Monitor renal function: especially in patients with existing kidney disease or dehydration. - Avoid in known NSAID hypersensitivity: discontinue if allergic reactions occur. - Use the lowest effective dose: to limit gastrointestinal and cardiovascular hazards. - Concurrent anticoagulant use: increase bleeding risk, require close monitoring. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Meloxicam can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Selective serotonin reuptake inhibitors (SSRIs): increased gastrointestinal bleed potential. - Lithium: meloxicam may raise lithium serum concentrations. - Methotrexate: reduced renal clearance leading to toxicity. - Cyclosporine: additive nephrotoxic effect.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: may impair renal function when combined. - Diuretics: risk of renal impairment and electrolyte disturbances. - Beta‑blockers: possible masking of hypertension symptoms. - Corticosteroids: additive risk of gastrointestinal ulceration. - Alcohol: enhances gastric irritation and bleeding risk.